A New Orleans startup exploring the diagnostic aspects of genetic research has received more than $1 million from investors and plans to expand its business. Pine Biotech, based at the New Orleans BioInnovation Center on Canal Street, has developed a software program to help scientists analyze and map large sets of molecular data — also […]
GAITHERSBURG, Md. — OpGen, Inc. (NASDAQ:OPGN) announced today that it has entered into a global supply agreement to use Thermo Fisher Scientific’s technology to support the commercialization of its rapid molecular products and informatics system to help combat multidrug-resistant infections. OpGen will combine Thermo Fisher’s real-time PCR solutions with its genomic analysis and bioinformatics technology […]
The Company reinforces its international exposure and commercial outreach through an alliance with a leading distributor in Asia (China, Hong-Kong and Macau) BAGNEUX, France Genomic Vision (Paris:GV) (FR0011799907 – GV), a company specialized in the development of diagnostic solutions for the early detection of cancers and genetic diseases today announced it has signed a business […]
Omics experimental methods are becoming critical in many areas of drug discovery, to allow the development of next generation, innovative therapeutics. Degenerative brain disorders affect more than 45 million people worldwide. These diseases often strike older adults and are characterized by progressive deterioration of nerve cells, eventually leading to cell death. Through human and animal […]
SAN FRANCISCO — Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, and the BioBricks Foundation today announced a groundbreaking agreement to provide 10,000 genes to the synthetic biology community. Under the terms of the agreement, the BioBricks Foundation (BBF) will pay for synthesis of 10,000 genes from Twist Bioscience. The BBF will […]
Innovative method delivers simple, accurate and cost-effective SNP analysis CORALVILLE, IA – Reflecting its mission to provide innovative solutions to the genomics community, Integrated DNA Technologies (IDT) introduces its unique rhAmp™ SNP Genotyping System, enabling researchers to make accurate and confident SNP calls both quickly and cost-effectively. rhAmp technology uses a unique RNase H2/DNA polymerase two-enzyme […]
SAN DIEGO, CA. — June 15, 2017— Molecular Assemblies Inc., a company developing a proprietary enzymatic DNA synthesis technology, today announced that it has expanded its board of directors with the appointment of Sean Freeman, NuVasive head of strategy and corporate development, to its board of directors. “Sean’s extensive business development experience in both strategic […]
SAN FRANCISCO, Calif. – Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, and the BioBricks Foundation today announced a groundbreaking agreement to provide 10,000 genes to the synthetic biology community. Under the terms of the agreement, the BioBricks Foundation (BBF) will pay for synthesis of 10,000 genes from Twist Bioscience. […]
Patent covers successful integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR Similar patents pending in other countries; anticipate favorable outcomes Billerica, Massachusetts — MilliporeSigma today announced that the Australian Patent Office has granted the company patent rights relating to the use of CRISPR in a genomic integration method for eukaryotic cells. The […]
Diagenode’s new agreement with the CeMM Research Center of Molecular Medicine of the Austrian Academy of Sciences will enable ChIP-sequencing from low input and difficult samples Denville, NJ, USA Liège, Belgium – Diagenode, a leading global provider for complete solutions for sample preparation and epigenetics research, has licensed a new technology specific for ChIP-sequencing from […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
